The 5-Minute Investor Podcast, Ep. 33: 10-bagger stocks

Welcome to episode 33 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute stock profile related to recent news stories with investment implications. This week, we’re talking about a pair of 10-bagger stocks, or stocks that have earned investors at least a 10x return over the past year, shedding light on what’s driving their superlative performances.

Here are Jon’s show notes for episode 33:

• A rising star in decentralized AI and enterprise intelligence.
• Jon’s 10-bagger stock is Intellistake Technologies (CSE:ISTK), a software developer bridging the gap between decentralized networks and real-world industry.
• At the time of writing, Intellistake stock traded at C$2.34.

Here are Trevor’s show notes:

• A 10-bagger healthcare technology stock worth the hype.
• Trevor’s 10-bagger stock is Hydreight Technologies (TSXV:NURS), a company building one of the United States’ largest mobile clinic networks.
• At the time of writing, Hydreight stock traded at C$4.11.

Here’s a list of recent episodes:

• Episode 27: Solid dividend stocks.
• Episode 28: Flow-through mining plays.
• Episode 29: Green infrastructure stocks.
• Episode 30: Underrated real estate stocks.
• Episode 31: Promising gaming stocks.
• Episode 32: Government-backed mining stocks.

Thanks for listening!

The 5-Minute Investor is on Spotify, YouTube, iHeartRadio, Podbean, Stockhouse or wherever finer podcasts are found.

Join the discussion: Find out what investors are saying about The 5-Minute Investor Podcast and these 10-bagger stocks on the Intellistake Technologies Corp. and Hydreight Technologies Inc. Bullboards, and make sure to explore the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.

For full disclaimer information, please click here.